These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8052511)

  • 1. The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica.
    Stitt AW; Fairweather I
    Parasitology; 1994 Jun; 108 ( Pt 5)():555-67. PubMed ID: 8052511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).
    Stitt AW; Fairweather I
    Parasitol Res; 1993; 79(7):529-36. PubMed ID: 8278333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
    McConville M; Brennan GP; McCoy M; Castillo R; Hernandez-Campos A; Ibarra F; Fairweather I
    Parasitology; 2006 Aug; 133(Pt 2):195-208. PubMed ID: 16650337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
    McConville M; Brennan GP; McCoy M; Castillo R; Hernandez-Campos A; Ibarra F; Fairweather I
    Parasitol Res; 2007 Jan; 100(2):365-77. PubMed ID: 17016729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Exp Parasitol; 2013 Nov; 135(3):642-53. PubMed ID: 24090567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasciola gigantica: tegumental surface alterations following treatment in vitro with the sulphoxide metabolite of triclabendazole.
    Meaney M; Fairweather I; Brennan GP; Ramasamy P; Subramanian PB
    Parasitol Res; 2002 Apr; 88(4):315-25. PubMed ID: 11999018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2011 Oct; 109(4):981-95. PubMed ID: 21442257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasciola hepatica: disruption of the vitelline cells in vitro by the sulphoxide metabolite of triclabendazole.
    Stitt AW; Fairweather I
    Parasitol Res; 1996; 82(4):333-9. PubMed ID: 8740549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica.
    Halferty L; Brennan GP; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2009 Feb; 159(2):126-38. PubMed ID: 19027238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2010 May; 106(6):1351-63. PubMed ID: 20336319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasciola hepatica: the effect of the microtubule inhibitors colchicine and tubulozole-C on the ultrastructure of the adult fluke.
    Stitt AW; Fairweather I
    Parasitology; 1993 Sep; 107 ( Pt 3)():297-309. PubMed ID: 8233593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasciola hepatica: ultrastructural changes to the tegument of juvenile flukes following incubation in vitro with the deacetylated (amine) metabolite of diamphenethide.
    Anderson HR; Fairweather I
    Int J Parasitol; 1995 Mar; 25(3):319-33. PubMed ID: 7601590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.
    McConville M; Brennan GP; Flanagan A; Edgar HW; McCoy M; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2008 May; 153(1-2):52-64. PubMed ID: 18359570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model.
    O'Neill JF; Johnston RC; Halferty L; Brennan GP; Keiser J; Fairweather I
    J Helminthol; 2009 Jun; 83(2):151-63. PubMed ID: 19368748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole.
    Robinson MW; Trudgett A; Hoey EM; Fairweather I
    Parasitology; 2002 Mar; 124(Pt 3):325-38. PubMed ID: 11922434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke.
    Meaney M; Allister J; McKinstry B; McLaughlin K; Brennan GP; Forbes AB; Fairweather I
    Parasitol Res; 2007 Apr; 100(5):1091-104. PubMed ID: 17180691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immature Fasciola gigantica: Time-dependent ultrastructural changes following in vivo treatment with triclabendazole.
    P A AS; S M A A
    Acta Trop; 2019 Aug; 196():15-21. PubMed ID: 31028722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of triclabendazole ("Fasinex") on protein synthesis by the liver fluke, Fasciola hepatica.
    Stitt AW; Fairweather I; Mackender RO
    Int J Parasitol; 1995 Apr; 25(4):421-9. PubMed ID: 7635617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole.
    Halferty L; Brennan GP; Hanna RE; Edgar HW; Meaney MM; McConville M; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2008 Aug; 155(1-2):49-58. PubMed ID: 18511199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
    Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
    Vet Parasitol; 2010 Dec; 174(3-4):218-27. PubMed ID: 20933333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.